Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement-Reference-Cited by-同舟云学术

Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement

Published:2023-12-08 Issue:1 Volume:124 Page:1-11
ISSN:0001-5458
Container-title:Acta Chirurgica Belgica
language:en
Short-container-title:Acta Chirurgica Belgica

Author:

Coropciuc Ruxandra¹^ORCID,Moreno-Rabié Catalina¹²^ORCID,De Vos Wouter³⁴,Van de Casteele Elke³⁴^ORCID,Marks Luc⁴⁵^ORCID,Lenaerts Vincent⁶,Coppejans Evy⁶,Lenssen Olivier⁷,Coopman Renaat⁸^ORCID,Walschap Jan⁹,Nadjmi Nasser³⁴^ORCID,Jacobs Reinhilde¹²¹⁰^ORCID,Politis Constantinus¹^ORCID,Van den Wyngaert Tim⁴¹¹^ORCID

Affiliation:

1. Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium

2. Department of Imaging and Pathology, OMFS-IMPATH Research Group, Faculty of Medicine, University of Leuven, Leuven, Belgium

3. Department of Oral and Maxillofacial Surgery, Antwerp University Hospital, Antwerp, Belgium

4. Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium

5. Special Care Dentistry, Antwerp University Hospital, Antwerp, Belgium

6. Department of Oral and Maxillofacial Surgery, VITAZ, Sint-Niklaas, Belgium

7. Department of Oral and Maxillofacial Surgery, ZNA Middelheim, Antwerpen, Belgium

8. Department of Oral and Maxillofacial and Plastic Surgery, University Hospital of Ghent, Ghent, Belgium

9. CMP Vlaanderen, Zoersel, Belgium

10. Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden

11. Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium

Funder

Kom op tegen Kanker (Stand up to Cancer) and the Flemish Cancer Society

Publisher

Informa UK Limited

Subject

General Medicine,Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/00015458.2023.2291295

Reference49 articles.

1. Bone health in cancer: ESMO Clinical Practice Guidelines

2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women

3. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome

4. Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

5. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study